Clinical Trials Directory

Trials / Completed

CompletedNCT04172610

Prevalence of Influenza RelAted Invasive Aspergillosis

The Prevalence of Influenza Related Invasive Aspergillosis in Swedish Intensive Care Units

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
Karolinska University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter study with the aim to determine the prevalence of influenza-related invasive pulmonary aspergillosis in Swedish intensive care units and to assess the clinical impact of and risk factors for influenza-related invasive pulmonary aspergillosis

Detailed description

This is a multicenter prospective observational study conducted at 12 intensive care units (ICU) in Sweden. All patients \>18 years of age with a Polymerase Chain Reaction (PCR)-verified influenza A or B diagnosed up to 7 days before admission to the ICU or during ICU care, will be included in the study. A new clinical routine has been implemented at the study centers: During the ICU stay screening with Beta-D-glucan and Galactomannan in blood/serum will be performed twice weekly and a respiratory sample will be retrieved for fungal culture and microscopy once weekly. All results from collected samples will be available to the patient's attending physicians. Clinical and microbiological data will be collected, and the diagnosis of invasive aspergillosis will be made using predefined diagnostic criteria. Objectives: 1. To determine the prevalence of influenza-related invasive pulmonary aspergillosis in Swedish intensive care units 2. To assess the clinical impact of and risk factors for influenza-related invasive pulmonary aspergillosis

Conditions

Timeline

Start date
2019-12-02
Primary completion
2023-04-14
Completion
2023-04-14
First posted
2019-11-21
Last updated
2023-07-06

Locations

12 sites across 1 country: Sweden

Source: ClinicalTrials.gov record NCT04172610. Inclusion in this directory is not an endorsement.